Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-05-29

Clinical Trial Update: The Effect of Calcitriol on Progress and Activity of Lupus Nephritis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating calcitriol for progression and activity in lupus nephritis associated with systemic lupus erythematosus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Calcitriol (calcitriol)

Snippet

Sponsor: Guilan University of Medical Sciences | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: UNKNOWN